Showing results (301-310 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|February 23, 2005
Computer-aided drug design strategies used in the discovery of fructose 1, 6-bisphosphatase inhibitorsM Rami Reddy, Mark D ErionCurrent Pharmaceutical Design|February 23, 2005
Computer-based strategy for modeling the interaction of AGRP and related peptide ligands with the AGRP-binding site of murine melanocortin receptorsXiang Wang, Nigel G J RichardsCurrent Pharmaceutical Design|February 23, 2005
Antiangiogenic agents: studies on fumagillin and curcumin analogsM S Furness, T P Robinson, T Ehlers, et al.Current Pharmaceutical Design|June 8, 2004
Targeting MAPK signalling: Prometheus' fire or Pandora's box?Simone Boldt, Walter KolchCurrent Pharmaceutical Design|June 8, 2004
Effects of HIV-1 entry inhibitors in combinationCecile TremblayCurrent Pharmaceutical Design|May 12, 2004
Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapyMaurizio Pellecchia, John C ReedCurrent Pharmaceutical Design|May 12, 2004
Chemistry and biology of curacin APeter Wipf, Jonathan T Reeves, Billy W DayCurrent Pharmaceutical Design|May 12, 2004
UR-3216: a new generation oral platelet GPIIb/IIIa antagonistYasuhiro Aga, Kosuke Baba, Susan Tam, et al.Current Pharmaceutical Design|May 12, 2004
Biochemical aspects of nitric oxideSofia Mariotto, Marta Menegazzi, Hisanori SuzukiCurrent Pharmaceutical Design|May 12, 2004
Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategiesRegoli DomenicoPageof 1,006